These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2053 related items for PubMed ID: 8784367

  • 1. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N, Le Deist F, Cant A, De Graeff-Meeders ER, Fasth A, Morgan G, Vellodi A, Hale G, Bujan W, Thomas C, Cavazzana-Calvo M, Wijdenes J, Fischer A.
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [Abstract] [Full Text] [Related]

  • 2. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 3. Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: a European Group for Immunodeficiency/European Group for Bone Marrow Transplantation report.
    Fischer A, Friedrich W, Fasth A, Blanche S, Le Deist F, Girault D, Veber F, Vossen J, Lopez M, Griscelli C.
    Blood; 1991 Jan 15; 77(2):249-56. PubMed ID: 1985691
    [Abstract] [Full Text] [Related]

  • 4. [T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient].
    Cavazzana-Calvo M, André-Schmutz I, Hacein-Bey S, Schindler J, Vitetta H, Dupuis S, Quartier P, Chedeville G, Vilmer E, Casanova JL, Buffet R, Caillat-Zucman S, Radford I, Le Deist F, Fischer A.
    J Soc Biol; 2001 Jan 15; 195(1):65-8. PubMed ID: 11530503
    [Abstract] [Full Text] [Related]

  • 5. In vivo infusion of anti LFA-1 antibody in HLA non-identical bone marrow transplantation in children: serum concentrations and biological effects.
    Perez N, Le Deist F, Chatenoud L, Chanteloup N, Griscelli C, Fischer A.
    Bone Marrow Transplant; 1989 Jul 15; 4(4):379-84. PubMed ID: 2673457
    [Abstract] [Full Text] [Related]

  • 6. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb.
    Patel NC, Chinen J, Rosenblatt HM, Hanson IC, Brown BS, Paul ME, Abramson SL, Ritz J, Shearer WT.
    J Allergy Clin Immunol; 2008 Dec 15; 122(6):1185-93. PubMed ID: 19084111
    [Abstract] [Full Text] [Related]

  • 7. Total lymphoid irradiation to prevent graft rejection in recipients of HLA non-identical T cell-depleted allogeneic marrow.
    Soiffer RJ, Mauch P, Tarbell NJ, Anderson KC, Freedman AS, Rabinowe SN, Takvorian T, Murrey CI, Coral F, Bosserman L.
    Bone Marrow Transplant; 1991 Jan 15; 7(1):23-33. PubMed ID: 2043874
    [Abstract] [Full Text] [Related]

  • 8. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.
    Koehler M, Hurwitz CA, Krance RA, Coustan-Smith E, Williams LL, Santana V, Ribeiro RC, Brenner MK, Heslop HE.
    Bone Marrow Transplant; 1994 May 15; 13(5):571-5. PubMed ID: 7519937
    [Abstract] [Full Text] [Related]

  • 9. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D.
    Klin Padiatr; 2005 May 15; 217(3):135-41. PubMed ID: 15858704
    [Abstract] [Full Text] [Related]

  • 10. Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy.
    Klein JL, Avalos BR, Belt P, Taylor CA, Ezzone SA, Scholl MD, Fisher J, Young D, Copelan EA.
    Bone Marrow Transplant; 1996 Apr 15; 17(4):479-83. PubMed ID: 8722342
    [Abstract] [Full Text] [Related]

  • 11. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR.
    Biol Blood Marrow Transplant; 2001 Apr 15; 7(11):620-30. PubMed ID: 11760150
    [Abstract] [Full Text] [Related]

  • 12. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
    Vossen J.
    Verh K Acad Geneeskd Belg; 1998 Apr 15; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
    [Abstract] [Full Text] [Related]

  • 13. Anti LFA1 monoclonal antibody for the prevention of graft rejection after T cell-depleted HLA-matched bone marrow transplantation for leukemia in adults.
    Maraninchi D, Mawas C, Stoppa AM, Gaspard MH, Marit G, Van Ekthoven A, Reiffers J, Olive D, Hirn M, Delaage M.
    Bone Marrow Transplant; 1989 Mar 15; 4(2):147-50. PubMed ID: 2650783
    [Abstract] [Full Text] [Related]

  • 14. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
    Ji SQ, Chen HR, Wang HX, Yan HM, Liu J, Xue M, Zhu L.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Aug 15; 24(8):416-9. PubMed ID: 14642179
    [Abstract] [Full Text] [Related]

  • 15. Prevention of bone marrow and cardiac graft rejection in an H-2 haplotype disparate mouse combination by an anti-LFA-1 antibody.
    Cavazzana-Calvo M, Sarnacki S, Haddad E, De Coene C, Calise D, Yvon E, Cerf-Bensussan N, Fischer A.
    Transplantation; 1995 Jun 15; 59(11):1576-82. PubMed ID: 7778173
    [Abstract] [Full Text] [Related]

  • 16. Minimizing graft rejection in allogeneic T cell-depleted bone marrow transplantation.
    Rigden JP, Cornetta K, Srour EF, Hanna M, Broun ER, Hromas R, Baute J, Hilton J, Cox E, Rubin L, Gonin R, Tricot G.
    Bone Marrow Transplant; 1996 Nov 15; 18(5):913-9. PubMed ID: 8932845
    [Abstract] [Full Text] [Related]

  • 17. In vitro analysis of donor bone marrow following monoclonal antibody treatment for the prevention of acute graft versus host disease.
    Kohler PC, Erickson C, Finlay JL, Trigg ME, Edwards B, Hong R, Hank JA, Billing R, Bozdech M, Sondel PM.
    Cancer Res; 1986 Oct 15; 46(10):5413-8. PubMed ID: 3530439
    [Abstract] [Full Text] [Related]

  • 18. The role of thiotepa in allogeneic bone marrow transplantation for genetic diseases.
    Rosales F, Peylan-Ramu N, Cividalli G, Varadi G, Or R, Naparstek E, Slavin S, Nagler A.
    Bone Marrow Transplant; 1999 May 15; 23(9):861-5. PubMed ID: 10338039
    [Abstract] [Full Text] [Related]

  • 19. Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency.
    Lanfranchi A, Verardi R, Tettoni K, Neva A, Mazzolari E, Pennacchio M, Pasic S, Ugazio AG, Albertini A, Porta F.
    Haematologica; 2000 Nov 15; 85(11 Suppl):41-6. PubMed ID: 11268323
    [Abstract] [Full Text] [Related]

  • 20. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
    Al-Mousa H, Al-Shammari Z, Al-Ghonaium A, Al-Dhekri H, Al-Muhsen S, Al-Saud B, Arnaout R, Al-Seraihy A, Al-Jefri A, Al-Ahmari A, Ayas M, El-Solh H.
    Biol Blood Marrow Transplant; 2010 Jun 15; 16(6):818-23. PubMed ID: 20079864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 103.